Drug product
Cetirizine HCL Oral Solution, USP 1mg/mL, 4 oz - BULK, PLD
D-1361-2019
Product summary
- Event
- Event 82889
- Status
- Terminated
- Classification
- Class II
- Quantity
- 361,260 bottles
- Official record key
drug-enforcement:D-1361-2019
Official wording
Reason: cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Code information: Lot #s: 17E015; 17E024; 17E044, Exp. 05/2019; 17F018, Exp. 06/2019; 17G012, Exp. 07/2019; 17K024, Exp. 10/2019; 17M004, Exp. 12/2019; 18B017, Exp. 02/2020; 18H023, Exp. 08/2020.
Distribution pattern: Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.
Derived failure modes
-
Manufacturing or process control
cGMP Deviations
-
Microbial contamination
contamination with Burkholderia cepacia (B.cepacia) and Ralstonia